Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma

Background: Lynch syndrome (LS) is not considered part of childhood cancer predisposition syndromes. Case presentation: Analysis of a pediatric osteosarcoma (OS) displayed hypermutation (16.8), alternative lengthening of telomeres (ALT), loss of PMS2 expression in tumor tissue (retained in non-neopl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kuhlen, Michaela (VerfasserIn) , Golas, Mariola Monika (VerfasserIn) , Schaller, Tina (VerfasserIn) , Stadler, Nicole (VerfasserIn) , Maier, Felicitas (VerfasserIn) , Witt, Olaf (VerfasserIn) , Frühwald, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2023
In: Hereditary cancer in clinical practice
Year: 2023, Jahrgang: 21, Pages: 1-6
ISSN:1897-4287
DOI:10.1186/s13053-023-00254-4
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13053-023-00254-4
Volltext
Verfasserangaben:Michaela Kuhlen, Mariola Monika Golas, Tina Schaller, Nicole Stadler, Felicitas Maier, Olaf Witt and Michael C. Frühwald

MARC

LEADER 00000caa a2200000 c 4500
001 1853553182
003 DE-627
005 20250113231046.0
007 cr uuu---uuuuu
008 230725s2023 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13053-023-00254-4  |2 doi 
035 |a (DE-627)1853553182 
035 |a (DE-599)KXP1853553182 
035 |a (OCoLC)1425213831 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kuhlen, Michaela  |d 1975-  |e VerfasserIn  |0 (DE-588)124082548  |0 (DE-627)085625965  |0 (DE-576)294012265  |4 aut 
245 1 0 |a Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma  |c Michaela Kuhlen, Mariola Monika Golas, Tina Schaller, Nicole Stadler, Felicitas Maier, Olaf Witt and Michael C. Frühwald 
264 1 |c 2023 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 12. Juni 2023 
500 |a Gesehen am 25.07.2023 
520 |a Background: Lynch syndrome (LS) is not considered part of childhood cancer predisposition syndromes. Case presentation: Analysis of a pediatric osteosarcoma (OS) displayed hypermutation (16.8), alternative lengthening of telomeres (ALT), loss of PMS2 expression in tumor tissue (retained in non-neoplastic cells), PMS2 loss of heterozygosity (LOH), and high-degree of microsatellite instability (MSI) tested by PCR. A heterozygous duplication c.1076dup p.(Leu359Phefs*6) in exon 10 of NM_000535.6:PMS2 was detected by SNV analysis in peripheral blood, confirming diagnosis of LS in the patient. The tumor molecular features suggest LS-associated development of OS. In a second case, whole-genome sequencing identified a heterozygous SNV c.1 A > T p.? in exon 1 of PMS2 in tumor and germline material of a girl with ependymoma. Tumor analysis displayed evidence for ALT and low mutational burden (0.6), PMS2 expression was retained, MSI was low. Multiplex ligation-dependent probe amplification identified no additional PMS2 variant and germline MSI testing did not reveal increased gMSI ratios in the patient´s lymphocytes. Thus, CMMRD was most closely excluded and our data do not suggest that ependymoma was related to LS in the child. Conclusions: Our data suggest that the LS cancer spectrum may include childhood cancer. The importance of LS in pediatric cancers necessitates prospective data collection. Comprehensive molecular workup of tumor samples is necessary to explore the causal role of germline genetic variants. 
650 4 |a Children 
650 4 |a Ependymoma 
650 4 |a Hereditary cancer predisposition 
650 4 |a Lynch syndrome 
650 4 |a Osteosarcoma 
650 4 |a PMS2 
700 1 |8 1\p  |a Golas, Mariola Monika  |d 1976-  |e VerfasserIn  |0 (DE-588)13288089X  |0 (DE-627)52788717X  |0 (DE-576)267148364  |4 aut 
700 1 |a Schaller, Tina  |e VerfasserIn  |4 aut 
700 1 |a Stadler, Nicole  |e VerfasserIn  |4 aut 
700 1 |a Maier, Felicitas  |e VerfasserIn  |4 aut 
700 1 |a Witt, Olaf  |d 1965-  |e VerfasserIn  |0 (DE-588)17275030X  |0 (DE-627)697681750  |0 (DE-576)133607410  |4 aut 
700 1 |8 2\p  |a Frühwald, Michael  |d 1966-  |e VerfasserIn  |0 (DE-588)1206269812  |0 (DE-627)1692264028  |4 aut 
773 0 8 |i Enthalten in  |t Hereditary cancer in clinical practice  |d Berlin : Springer, 2003  |g 21(2023), Artikel-ID 8, Seite 1-6  |h Online-Ressource  |w (DE-627)511229925  |w (DE-600)2233352-6  |w (DE-576)33710204X  |x 1897-4287  |7 nnas  |a Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma 
773 1 8 |g volume:21  |g year:2023  |g elocationid:8  |g pages:1-6  |g extent:6  |a Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma 
856 4 0 |u https://doi.org/10.1186/s13053-023-00254-4  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 2\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20230725 
993 |a Article 
994 |a 2023 
998 |g 17275030X  |a Witt, Olaf  |m 17275030X:Witt, Olaf  |d 910000  |d 910500  |e 910000PW17275030X  |e 910500PW17275030X  |k 0/910000/  |k 1/910000/910500/  |p 6 
999 |a KXP-PPN1853553182  |e 4357412692 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1853553182"],"doi":["10.1186/s13053-023-00254-4"]},"recId":"1853553182","origin":[{"dateIssuedDisp":"2023","dateIssuedKey":"2023"}],"name":{"displayForm":["Michaela Kuhlen, Mariola Monika Golas, Tina Schaller, Nicole Stadler, Felicitas Maier, Olaf Witt and Michael C. Frühwald"]},"language":["eng"],"note":["Veröffentlicht: 12. Juni 2023","Gesehen am 25.07.2023"],"person":[{"display":"Kuhlen, Michaela","family":"Kuhlen","role":"aut","given":"Michaela"},{"display":"Golas, Mariola Monika","role":"aut","family":"Golas","given":"Mariola Monika"},{"given":"Tina","family":"Schaller","role":"aut","display":"Schaller, Tina"},{"given":"Nicole","display":"Stadler, Nicole","family":"Stadler","role":"aut"},{"role":"aut","family":"Maier","display":"Maier, Felicitas","given":"Felicitas"},{"display":"Witt, Olaf","role":"aut","family":"Witt","given":"Olaf"},{"given":"Michael","display":"Frühwald, Michael","role":"aut","family":"Frühwald"}],"relHost":[{"recId":"511229925","id":{"issn":["1897-4287"],"eki":["511229925"],"zdb":["2233352-6"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and EpendymomaHereditary cancer in clinical practice","origin":[{"publisher":"Springer ; PubMed Central ; BioMed Central","publisherPlace":"Berlin ; Heidelberg ; Bethesda, MD ; London","dateIssuedKey":"2003","dateIssuedDisp":"2003-"}],"corporate":[{"role":"isb","display":"Mie̜dzynarodowe Centrum Nowotworów Dziedzicznych"}],"note":["Erscheint vierteljährlich","Fortsetzung der Druck-Ausgabe","Gesehen am 25.02.2025","Volltext auch als Teil einer Datenbank verfügbar"],"pubHistory":["1.2003,1(Dez.); 2.2004 -"],"language":["eng"],"part":{"extent":"6","volume":"21","pages":"1-6","text":"21(2023), Artikel-ID 8, Seite 1-6","year":"2023"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Hereditary cancer in clinical practice","subtitle":"the official journal of the International Hereditary Cancer Center, Pomeranian Medical University","title":"Hereditary cancer in clinical practice"}]}],"title":[{"title_sort":"Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma","title":"Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma"}],"physDesc":[{"extent":"6 S."}]} 
SRT |a KUHLENMICHBEYONDGERM2023